In this context, we could demonstrate, for the first time, that miR-130a-3p and miR-148a-3p both target Bcl-2 directly in ESCC, and that miR-125a-5p targets p53 directly in this tumor type. Here, BCL2 is linked to esophageal squamous cell carcinoma.